Risk factors for secondary lymphoedema include the extent of lymph node removal, radiation therapy, surgical trauma, obesity, and lack of limb mobility
[For more on this, see Stanford Medicines reporting on GLP-1s and addiction.] Some of these effects like those on cardiovascular disease and sleep apnea have been well studied, but not every proposed use will pan out
The clinical data tells a clear story
This adaptation persists after stopping GLP-1 medications and contributes to weight regain
A lot of patients wind up in a maxillofacial consult for the first time in their adult lives after a year on a GLP-1, and theyre not imagining things
Timing plays a crucial role symptoms tend to peak during the first 45 weeks of treatment when gastric emptying slows the most